Press Resease

In Vivo Toxicology Market by Product (Instruments, Animal models, and Reagents & Kits), by Testing Type (Chronic Toxicity Testing, Sub-chronic Toxicity Testing, Sub-acute Toxicity Testing, and Acute Toxicity Testing), and by Toxicity Endpoints (Systemic Toxicity, Immunotoxicity, and DART): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Published Date: 28-Aug-2018 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-3299 Status : Published

Global in vivo toxicology market expected to generate revenue of around USD 6,609.87 million by end of 2024, growing at a CAGR of around 6.84% between 2018 and 2024. Toxicology is the domain of science that studies the adverse effects of chemicals and substances on living organisms and surroundings.

Description

The report covers forecast and analysis for the in vivo toxicology market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the in vivo toxicology market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the in vivo toxicology market on a global as well as regional level.

In order to give the users of this report a comprehensive view of the in vivo toxicology market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global In Vivo Toxicology Market

The report provides company market share analysis in order to give a broader overview of the key players in the in vivo toxicology market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the in vivo toxicology market on the global and regional basis. 

The study provides a decisive view of the in vivo toxicology market by segmenting the market based on product, testing type, toxicity endpoints, and regions. The segments have been analyzed based on present and the future trends and the market is estimated from 2018 to 2024. The product segment is segmented into instruments, animal models, and reagents & kits. Animal models segment held the maximum share of the product segment owing to rise in the development of genetically modified animals. Based on the testing type, in vivo toxicology market is segmented into chronic toxicity testing, sub-chronic toxicity testing, sub-acute toxicity testing, and acute toxicity testing. Based on toxicity endpoints, in vivo toxicology market is segmented into systemic toxicity, immunotoxicity, and DART.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East & Africa with its further division into major countries including the U.S., Canada, Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for in vivo toxicology based on the individual segment in all the regions and countries.

The report also includes detailed profiles of end players such as Danaher, Charles River, Thermo Fisher, The Jackson Laboratory, and Covance, among others.

This report segments the global in vivo toxicology market as follows:

Global In Vivo Toxicology Market: By Product

  • Instruments
  • Animal models
  • Reagents & Kits

Global In Vivo Toxicology Market: By Testing Type

  • Chronic Toxicity Testing
  • Sub-chronic Toxicity Testing
  • Sub-acute Toxicity Testing
  • Acute Toxicity Testing

Global In Vivo Toxicology Market: By Toxicity Endpoints

  • Systemic Toxicity
  • Immunotoxicity
  • DART

Global In Vivo Toxicology Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global In Vivo Toxicology market, 2017 - 2024 (USD Million)
    • 2.2. Global In Vivo Toxicology market : Snapshot
  •  
  • Chapter 3. In Vivo Toxicology- Market Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global in vivo toxicology market drivers: Impact analysis
      • 3.2.2. Rise in pharmaceutical research and development activities
      • 3.2.3. Development of exclusive in vivo toxicology tests
    • 3.3. Market restraints
      • 3.3.1. Drawbacks of animal testing
      • 3.3.2. Rising demand to develop and undertake substitute animal testing methods
    • 3.4. Opportunities
      • 3.4.1. Increasing focus on development of personalized medicine
      • 3.4.2. Increasing demand for humanized animal models
    • 3.5. Porter's five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by product segment
      • 3.6.2. Market attractiveness analysis, by testing type segment
      • 3.6.3. Market attractiveness analysis, by toxicity endpoints segment
  •  
  • Chapter 4. Global In Vivo Toxicology Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global in vivo toxicology market: company market share, 2017
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research and Development, Regional Expansion
  •  
  • Chapter 5. Global In Vivo Toxicology Market - Product Segment Analysis
    • 5.1. Global in vivo toxicology market: Product overview
      • 5.1.1. Global in vivo toxicology market revenue share, by Product, 2017 and 2024
    • 5.2. Instruments
      • 5.2.1. Global in vivo toxicology market for Instruments, 2017 - 2024 (USD Million)
    • 5.3. Animal models
      • 5.3.1. Global in vivo toxicology market for Animal models, 2017 - 2024 (USD Million)
    • 5.4. Reagents & Kits
      • 5.4.1. Global in vivo toxicology market for Reagents & Kits, 2017 - 2024 (USD Million)
  •  
  • Chapter 6. Global In Vivo Toxicology Market - Testing Type Segment Analysis
    • 6.1. Global in vivo toxicology market: Testing Type overview
      • 6.1.1. Global in vivo toxicology market revenue share, by Testing Type, 2017 and 2024
    • 6.2. Chronic Toxicity Testing
      • 6.2.1. Global in vivo toxicology market for Chronic Toxicity Testing, 2017 - 2024 (USD Million)
    • 6.3. Sub-chronic Toxicity Testing
      • 6.3.1. Global in vivo toxicology market for Sub-chronic Toxicity Testing, 2017 - 2024 (USD Million)
    • 6.4. Sub-acute Toxicity Testing
      • 6.4.1. Global in vivo toxicology market for Sub-acute Toxicity Testing, 2017 - 2024 (USD Million)
    • 6.5. Acute Toxicity Testing
      • 6.5.1. Global in vivo toxicology market for Acute Toxicity Testing, 2017 - 2024 (USD Million)
  •  
  • Chapter 7. Global In Vivo Toxicology Market - Toxicity Endpoints Segment Analysis
    • 7.1. Global in vivo toxicology market: Toxicity Endpoints overview
      • 7.1.1. Global in vivo toxicology market revenue share, by Toxicity Endpoints, 2017 and 2024
    • 7.2. Systemic Toxicity
      • 7.2.1. Global in vivo toxicology market for Systemic Toxicity, 2017 - 2024 (USD Million)
    • 7.3. Immunotoxicity
      • 7.3.1. Global in vivo toxicology market for Immunotoxicity, 2017 - 2024 (USD Million)
    • 7.4. DART
      • 7.4.1. Global in vivo toxicology market for DART, 2017 - 2024 (USD Million)
  •  
  • Chapter 8. Global In Vivo Toxicology Market - Regional Segment Analysis
    • 8.1. Global in vivo toxicology market: Regional overview
      • 8.1.1. Global in vivo toxicology market revenue share, by region, 2017 and 2024
    • 8.2. North America
      • 8.2.1. North America in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
      • 8.2.2. North America in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
      • 8.2.3. North America in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
      • 8.2.4. U.S.
        • 8.2.4.1. U.S. in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
        • 8.2.4.2. U.S. in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
        • 8.2.4.3. U.S. in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
      • 8.2.5. Canada
        • 8.2.5.1. Canada in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
        • 8.2.5.2. Canada in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
        • 8.2.5.3. Canada in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
      • 8.2.6. Rest of North America
        • 8.2.6.1. Rest of North America in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
        • 8.2.6.2. Rest of North America in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
        • 8.2.6.3. Rest of North America in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
      • 8.3.2. Europe in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
      • 8.3.3. Europe in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
      • 8.3.4. Germany
        • 8.3.4.1. Germany in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
        • 8.3.4.2. Germany in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
        • 8.3.4.3. Germany in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
      • 8.3.5. U.K.
        • 8.3.5.1. U.K. in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
        • 8.3.5.2. U.K. in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
        • 8.3.5.3. U.K. in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
      • 8.3.6. France
        • 8.3.6.1. France in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
        • 8.3.6.2. France in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
        • 8.3.6.3. France in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
      • 8.3.7. Italy
        • 8.3.7.1. Italy in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
        • 8.3.7.2. Italy in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
        • 8.3.7.3. Italy in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
      • 8.3.8. Spain
        • 8.3.8.1. Spain in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
        • 8.3.8.2. Spain in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
        • 8.3.8.3. Spain in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
      • 8.3.9. Russia
        • 8.3.9.1. Russia in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
        • 8.3.9.2. Russia in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
        • 8.3.9.3. Russia in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
      • 8.3.10. Rest of Europe
        • 8.3.10.1. Rest of Europe in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
        • 8.3.10.2. Rest of Europe in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
        • 8.3.10.3. Rest of Europe in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
      • 8.4.2. Asia Pacific in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
      • 8.4.3. Asia Pacific in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
      • 8.4.4. China
        • 8.4.4.1. China in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
        • 8.4.4.2. China in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
        • 8.4.4.3. China in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
      • 8.4.5. Japan
        • 8.4.5.1. Japan in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
        • 8.4.5.2. Japan in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
        • 8.4.5.3. Japan in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
      • 8.4.6. India
        • 8.4.6.1. India in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
        • 8.4.6.2. India in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
        • 8.4.6.3. India in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
      • 8.4.7. Australia
        • 8.4.7.1. Australia in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
        • 8.4.7.2. Australia in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
        • 8.4.7.3. Australia in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
        • 8.4.8.2. Rest of Asia Pacific in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
        • 8.4.8.3. Rest of Asia Pacific in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
      • 8.5.2. Latin America in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
      • 8.5.3. Latin America in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
        • 8.5.4.2. Brazil in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
        • 8.5.4.3. Brazil in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
      • 8.5.5. Mexico
        • 8.5.5.1. Mexico in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
        • 8.5.5.2. Mexico in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
        • 8.5.5.3. Mexico in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
      • 8.5.6. Argentina
        • 8.5.6.1. Argentina in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
        • 8.5.6.2. Argentina in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
        • 8.5.6.3. Argentina in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
      • 8.5.7. Rest of Latin America
        • 8.5.7.1. Rest of Latin America in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
        • 8.5.7.2. Rest of Latin America in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
        • 8.5.7.3. Rest of Latin America in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
    • 8.6. Middle East and Africa
      • 8.6.1. Middle East and Africa in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
      • 8.6.2. Middle East and Africa in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
      • 8.6.3. Middle East and Africa in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
      • 8.6.4. Saudi Arabia
        • 8.6.4.1. Saudi Arabia in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
        • 8.6.4.2. Saudi Arabia in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
        • 8.6.4.3. Saudi Arabia in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
      • 8.6.5. UAE
        • 8.6.5.1. UAE in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
        • 8.6.5.2. UAE in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
        • 8.6.5.3. UAE in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
      • 8.6.6. South Africa
        • 8.6.6.1. South Africa in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
        • 8.6.6.2. South Africa in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
        • 8.6.6.3. South Africa in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
      • 8.6.7. Qatar
        • 8.6.7.1. Qatar in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
        • 8.6.7.2. Qatar in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
        • 8.6.7.3. Qatar in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
      • 8.6.8. Rest of Middle East and Africa
        • 8.6.8.1. Rest of Middle East and Africa in vivo toxicology market revenue, by Product, 2017 - 2024 (USD Million)
        • 8.6.8.2. Rest of Middle East and Africa in vivo toxicology market revenue, by Testing Type, 2017 - 2024 (USD Million)
        • 8.6.8.3. Rest of Middle East and Africa in vivo toxicology market revenue, by Toxicity Endpoints, 2017 - 2024 (USD Million)
  •  
  • Chapter 9. Company Profile
    • 9.1. Danaher
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Therapy portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. Charles River
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Therapy portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. Thermo Fisher
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Therapy portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. The Jackson Laboratory
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Therapy portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. Covance
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Therapy portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments

Methodology

Free Analysis

Toxicology is the domain of science that studies the adverse effects of chemicals and substances on living organisms and the surroundings. Toxicology also includes diagnosis and treatment of exposure to toxins. In toxicology, dosage has a great importance and is directly linked to the effects experienced by the individuals. Almost all the substances can act as a toxin if not given in the right dose and conditions. In vivo toxicology studies the effects of toxins within living organisms. In vivo toxicity testing is done majorly on experimental organisms. In vivo toxicological testing forms a very important part of the development process of new drugs. It is very important to test the toxicity potential of new molecules in animals. In vivo toxicology also studies the administration route of new drugs.

Toxicity testing is majorly divided into chronic and acute toxicity testing. Chronic toxicity testing monitors the ill effects developed due to prolonged exposure to toxic substances. Acute toxicity testing monitors the adverse effects caused from alone exposure or numerous exposures in a short span of time. In vivo toxicological testing methods are adopted to find the harmful properties of chemicals. In vivo toxicological testing helps in understanding the biological responses of individuals to toxin exposure. During the development process of new drugs, in vivo toxicology helps in minimizing the adverse effects of molecules. Animal models are used to test the chemicals for toxicity. In vivo toxicology is also used to test the effects of toxic substances in the immune system. Studies are conducted on animals to observe the effects of industrial and environmental chemicals on the immune system.

Global In Vivo Toxicology Market

Costs related to pharmaceuticals form a significant part of the overall healthcare spending. To bring new drugs and therapies, manufacturers need to conduct extensive research and development through clinical trials. Pharmaceutical companies spend billions of dollars to conduct clinical research. The number of clinical trials is constantly on the rise. According to the ClinicalTrials.gov, a total of 281,305 studies are registered on their database as of August 2018. The U.S. Food and Drugs Administration approved 46 novel drugs in 2017. In recent years, regulatory authorities have introduced strict guidelines for animal testing. Pharmaceutical companies are required to conduct a complete study of the effects of molecules on living organisms.

Factors such as a rise in pharmaceutical research and development activities, compulsory animal testing regulations, modernization of animal models will drive the growth of the global in vivo toxicology market. Moreover, the advancement of unique in vivo toxicology tests is expected to boost the global in vivo toxicology market. The surge in oncology research, increasing focus on the development of personalized medicine, and increasing demand for humanized animal models can act as a golden opportunity for the in vivo toxicology market. Nevertheless, drawbacks of animal testing and rising demand to develop and undertake substitute animal testing methods can restrict the growth of global in vivo toxicology market.    

The global in vivo toxicology market is segmented into the product, testing type, toxicity endpoints, and region. The product segment has been segmented into instruments, animal models, and reagents & kits. Animal models segment held the maximum share of the product segment owing to rise in the development of genetically modified animals. Based on the testing type, in vivo toxicology market is segmented into chronic toxicity testing, sub-chronic toxicity testing, sub-acute toxicity testing, and acute toxicity testing. Based on the toxicity endpoints, in vivo toxicology market is segmented into systemic toxicity, immunotoxicity, and DART.

North America will be the dominant region during the forecast period. Rising research and development funding and the presence of major pharmaceutical companies will boost the market in this region. Europe anticipates being the second largest market. The Asia Pacific will grow at the fastest rate over the forecast period. Efforts taken by the Chinese government to promote life science research and growing commercialization of biotechnology research are the driving factors for the growth of the in vivo toxicology market in this region. Latin America market is projected to grow at a moderate rate during the forecast period. The Middle East and Africa are expected to experience noticeable growth in the years to come.
Some of the key players in the market include Danaher, Charles River, Thermo Fisher, The Jackson Laboratory, and Covance, among others.

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Accept

We have secured system to process your transaction.


We Are On Social